Skip to main content
Clinical Trials/NCT00950079
NCT00950079
Unknown
Phase 4

Preventive Strategies of REnal Insufficiency in Patients With Diabetes Undergoing InterVENTion or Arteriography(PREVENT Trial)

CardioVascular Research Foundation, Korea9 sites in 1 country368 target enrollmentFebruary 2008

Overview

Phase
Phase 4
Intervention
Sodium bicarbonate
Conditions
Contrast Induced Nephropathy
Sponsor
CardioVascular Research Foundation, Korea
Enrollment
368
Locations
9
Primary Endpoint
Incidence of contrast-induced nephropathy
Last Updated
16 years ago

Overview

Brief Summary

The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing coronary angiography or intervention.

Detailed Description

Contrast induced nephropathy (CIN) is a common cause of renal failure associated with prolonged hospitalization, significant morbidity or mortality, and cost. CIN has been reported to account for 10% of hospital acquired renal failure. Several strategies or medications were tried to prevent CIN. Of these, mucomyst and normal saline infusion are effective to prevent CIN. Sodium bicarbonate has shown mixed results from recent randomized trials. Moreover,limited data have been available for preventing CIN in diabetic renal dysfunction undergoing coronary angiography or intervention. Our hypothesis is that addition of sodium bicarbonate will be more efficacious than normal saline in preventing CIN at above situation.

Registry
clinicaltrials.gov
Start Date
February 2008
End Date
January 2010
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
CardioVascular Research Foundation, Korea

Eligibility Criteria

Inclusion Criteria

  • age\>18 years, no upper limits
  • diabetes treated with insulin or oral hypoglycemic agents
  • serum creatinine \>=1.1 and
  • resting estimated glomerular filtration rate \<60ml/min/1.73 square meter

Exclusion Criteria

  • serum creatinine \>=8mg/dL
  • resting estimated GFR \<15ml/min/1.73 square meter
  • end stage renal disease on hemodialysis
  • multiple myeloma
  • uncontrolled hypertension (systolic BP \>160mmHg or diastolic BP\>100mmHg)
  • acute myocardial infarction
  • emergent coronary angioplasty or angiography
  • recent use of contrast within 2 days
  • allergic reaction to contrast
  • pregnancy

Arms & Interventions

Sodium bicarbonate

sodium bicarbonate

Intervention: Sodium bicarbonate

Saline

saline infusion

Intervention: saline

Outcomes

Primary Outcomes

Incidence of contrast-induced nephropathy

Time Frame: 24 and 48 hours after angiography or intervention

Secondary Outcomes

  • all-cause mortality(30 days to 6 months after index angiography)
  • stroke(30 days to 6 months after index angiography)
  • Dialysis(30 days after index angiography)
  • Myocardial infarction(30 days after index angiography)
  • dialysis(30 days to 6 months after index angiography)
  • myocardial infarction(30 days to 6 months after index angiography)

Study Sites (9)

Loading locations...

Similar Trials